We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-7.99%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.4B
AUM Growth
-$2.28B
Cap. Flow
-$623M
Cap. Flow %
-3.38%
Top 10 Hldgs %
32.43%
Holding
345
New
22
Increased
43
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$314M
2
DT icon
Dynatrace
DT
+$312M
3
CSGP icon
CoStar Group
CSGP
+$301M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$249M
5
CLVT icon
Clarivate
CLVT
+$237M

Top Sells

Rank Stock Value
1
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$411M
2
RTX icon
RTX Corp
RTX
+$335M
3
CERN
Cerner Corp
CERN
+$312M
4
AVGO icon
Broadcom
AVGO
+$257M
5
PLAN
Anaplan, Inc.
PLAN
+$102M

Sector Composition

Rank Sector Weight
1 Healthcare 30.85%
2 Technology 17.59%
3 Financials 14.68%
4 Industrials 9.18%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMPX icon
301
Compass Therapeutics
CMPX
$387M
– –
-582,750
Closed -$798K
DRIO icon
302
DarioHealth
DRIO
$71.2M
– –
-6,654
Closed -$777K
EXAS
303
DELISTED
Exact Sciences
EXAS
– –
-802,898
Closed -$56.1M
FATE icon
304
Fate Therapeutics
FATE
$326M
– –
-31,900
Closed -$1.24M
KYNB
305
Kyntra Bio
KYNB
$29.4M
– –
-14,591
Closed -$4.38M
GROV icon
306
Grove Collaborative
GROV
$46.1M
– –
-200,000
Closed -$9.86M
PACB icon
307
Pacific Biosciences
PACB
$368M
– –
-1,631,800
Closed -$14.8M
RGEN icon
308
Repligen
RGEN
$9.25B
– –
-222,979
Closed -$41.9M
RTX icon
309
RTX Corp
RTX
$301B
– –
-3,385,484
Closed -$335M
VCYT icon
310
Veracyte
VCYT
$3.8B
– –
-32,500
Closed -$896K
PNT
311
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-626,322
Closed -$4.99M
SPCMU
312
DELISTED
Sound Point Acquisition Corp I, Ltd Unit
SPCMU
– –
-300,000
Closed -$3.02M
GBT
313
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-169,458
Closed -$5.87M
ZEAL
314
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
– –
-496,890
Closed -$7.75M
PLAN
315
DELISTED
Anaplan, Inc.
PLAN
– –
-1,570,000
Closed -$102M
VGII.WS
316
DELISTED
Virgin Group Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one Class
VGII.WS
– –
-200,000
Closed -$76K
DIDI
317
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
– –
-16,868,328
Closed -$42.2M
CERN
318
DELISTED
Cerner Corp
CERN
– –
-3,339,955
Closed -$312M
CAS.WS
319
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
– –
-495,000
Closed -$87K
CAS
320
DELISTED
Cascade Acquisition Corp.
CAS
– –
-990,000
Closed -$9.98M
OCDX
321
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
– –
-2,426,913
Closed -$45.3M
ZNGA
322
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-44,475,000
Closed -$411M
ZNGA
323
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-1,500,000
Closed -$13.9M
FOE
324
DELISTED
Ferro Corporation
FOE
– –
-114,963
Closed -$2.5M
PBCT
325
DELISTED
People's United Financial Inc
PBCT
– –
-485,000
Closed -$9.7M
10 11 12
13
14

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Farallon Capital Management held 345 positions worth $18.4B, down 11% from $20.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management withdrew a net $623M in Q2 2022, closing 30 positions and reducing 37 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $411M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Twitter, Inc. worth $274M.

  • Farallon Capital Management's largest Q2 2022 buy was Twitter, Inc.: 7,325,000 shares worth $274M.
  • Farallon Capital Management added most to Clarivate in Q2 2022, an estimated $237M increase.
  • Farallon Capital Management's biggest Q2 2022 reduction was AbbVie, cutting an estimated $97.7M.
  • Farallon Capital Management fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $411M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $18.4B portfolio in Q2 2022.
  • Farallon Capital Management opened 22 new positions and closed 30 in Q2 2022.
  • Farallon Capital Management's portfolio value fell 11% quarter-over-quarter to $18.4B.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.